UA13922A - Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action - Google Patents

Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action

Info

Publication number
UA13922A
UA13922A UA95041881A UA95041881A UA13922A UA 13922 A UA13922 A UA 13922A UA 95041881 A UA95041881 A UA 95041881A UA 95041881 A UA95041881 A UA 95041881A UA 13922 A UA13922 A UA 13922A
Authority
UA
Ukraine
Prior art keywords
blocking
producing
factor
contrinsulinic
receptor
Prior art date
Application number
UA95041881A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Вадим Валерійович Корпачев
Вадим Валериевич Корпачев
Наталія Марківна Гуріна
Наталья Марковна Гурина
Жана Вікторівна Іванова
Жанна Викторовна Иванова
Original Assignee
Інститут Ендокринології Та Обміну Речовин Ім. В.В.Комісаренка Амh України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Ендокринології Та Обміну Речовин Ім. В.В.Комісаренка Амh України filed Critical Інститут Ендокринології Та Обміну Речовин Ім. В.В.Комісаренка Амh України
Priority to UA95041881A priority Critical patent/UA13922A/en
Publication of UA13922A publication Critical patent/UA13922A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicine, in particular to endocrinology, to methods for producing of counter insulin factor, blocking of insulin binding, which can be used for study of causation and pathogenesis of diabetes mellitus and other insulin-resistant states in experimental endocrinology, pharmacology, biochemistry and pathophysiology. The method provides blood treatment with anticoagulant, plasma separation and its fractionation.
UA95041881A 1995-04-25 1995-04-25 Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action UA13922A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA95041881A UA13922A (en) 1995-04-25 1995-04-25 Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA95041881A UA13922A (en) 1995-04-25 1995-04-25 Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action

Publications (1)

Publication Number Publication Date
UA13922A true UA13922A (en) 1997-04-25

Family

ID=74549984

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95041881A UA13922A (en) 1995-04-25 1995-04-25 Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action

Country Status (1)

Country Link
UA (1) UA13922A (en)

Similar Documents

Publication Publication Date Title
Gejyo et al. A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin
IE891798L (en) Novel ó-glucosidase inhibitors
NO20073489L (en) Method and apparatus for delivering epinephrine
AR034049A1 (en) USE OF ANTI-TNF ANTIBODIES AS PHARMACES IN THE TREATMENT OF SEPTIC DISORDERS OF AEMIC PATIENTS
AU1520195A (en) Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
HK1025738A1 (en) Lo-cd2a antibody and uses thereof for inhibiting tcell activation and proliferation
DE69226835D1 (en) METHODS AND COMPOSITIONS FOR TREATING DIABETES MELLITUS, HYPOGLYCAEMIA AND OTHER DISEASES
DK0690721T3 (en) Treatment of Mycobacterial Diseases by Administration of Bactericidal / Permeability-Increasing Protein Products
ATA309588A (en) NEW CICLOSPORIN CRYSTAL SHAPE, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING THIS CRYSTAL SHAPE, AND USE OF THIS CRYSTAL SHAPE
AU3137699A (en) Novel process for the separation of proteins using a Ca ++ containing eluant
ATE234111T1 (en) THERAPEUTIC USES OF BPI PROTEIN PRODUCTS IN PEOPLE WITH BLEEDING CAUSED BY TRAUMA
DE68922202D1 (en) A new thrombomodulin-like glycoprotein available from urine.
EA199800685A1 (en) SEPARATION OF COMPONENTS OF BLOOD PLASMA BY MEANS OF FILTERING MEANS ON THE BASIS OF CELLULOSE
UA13922A (en) Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action
DK0687300T3 (en) LO-CD2a antibody and its uses for inhibiting T cell activation and proliferation
UA13921A (en) Method for producing of contrreceptor factor, blocking of insulin binding with its receptor and having of diabetogenic action
ATE263779T1 (en) AQUEOUS PROTEIN COMPOSITION, CONTAINING GLYCOPROTEINS, METHOD FOR PRODUCTION AND USES
ATE264112T1 (en) USE OF IL-7 FOR THE TREATMENT OF AUTOIMMUNE DISEASES, PARTICULARLY INSULIN-DEPENDENT DIABETES MELLITUS
CO4820397A1 (en) TREATMENT AGAINST ASTHMA WITH TNFR -Ig
AU6953296A (en) Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation
AU687451B2 (en) Process for producing a virus-inactivated factor VIII-containing fraction by chromatographic methods
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
UA13923A (en) Method for differential diagnostics of subtypes of insulin-independent pancreatic diabetes
KR970020139A (en) Purification of Bromeline
UA42351A (en) Method for treating tuberculosis